Skip Nav Destination
Issues
1 October 2012
-
Cover Image
Cover Image
Activation of fibroblast growth factor receptor 1 (FGFR1) in mammary epithelial cells induces recruitment of macrophages to the mammary epithelium, which contributes to FGFR1-induced tumor formation. Using 3D co-culture assays in which FGFR1 was activated specifically in mammary epithelial cells, macrophages were found to associate with the epithelial structures and induce invasion of the cells into the surrounding basement membrane matrix. Further studies demonstrated that this interaction was dependent upon increased secretion of Cxcr2-binding chemokines by macrophages following exposure to FGFR1-induced soluble factors produced by the epithelium. For details see Bohrer and Schwertfeger on page 1294. - PDF Icon PDF LinkTable of Contents
ISSN 1541-7786
EISSN 1557-3125
Molecular Cancer Research
Table of Contents
Highlights
Reviews
Angiogenesis, Metastasis, and the Cellular Microenvironment
Cancer Genes and Genomics
Cell Cycle, Cell Death, and Senescence
DNA Damage and Cellular Stress Responses
Signaling and Regulation
Biological Responses to TGF-β in the Mammary Epithelium Show a Complex Dependency on Smad3 Gene Dosage with Important Implications for Tumor Progression
Ethan A. Kohn; Yu-an Yang; Zhijun Du; Yoshiko Nagano; Catherine M.H. Van Schyndle; Michelle A. Herrmann; Madeleine Heldman; Jin-Qiu Chen; Christina H. Stuelten; Kathleen C. Flanders; Lalage M. Wakefield
Journal Archive
Molecular Cancer Research
(2002-Present; volumes 1-current)Published monthly since November, 2002.
(ISSN 0008-5472)
Cell Growth & Differentiation
(1990-2002; volumes 1-13)Published monthly 1990- September, 2002.
(ISSN 1044-9523)
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.